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Background-—No longitudinal study compared associations of echocardiographic indexes of diastolic left ventricular function
studies with conventional (CBP) and daytime ambulatory (ABP) blood pressure in the general population.
Methods and Results-—In 780 Flemish (mean age, 50.2 years; 51.7% women), we measured left atrial volume index (LAVI), peak
velocities of the transmitral blood ﬂow (E) and mitral annular movement (e0) in early diastole and E/e0 9.6 years (median) after CBP
and ABP. In adjusted models including CBP and ABP, we expressed associations per 10/5-mm Hg systolic/diastolic blood
pressure increments. LAVI and E/e0 were 0.65/0.40 mL/m2 and 0.17/0.09 greater with higher systolic/diastolic ABP (P≤0.028),
but not with higher baseline CBP (P≥0.086). e0 was lower (P≤0.032) with higher diastolic CBP (0.09 cm/s) and ABP (0.19 cm/
s). When we substituted baseline CBP by CBP recorded concurrently with echocardiography, LAVI and E/e0 remained 0.45/
0.38 mL/m2 and 0.15/0.08 greater with baseline ABP (P≤0.036), while LAVI (+0.53 mL/m2) and E/e0 (+0.19) were also greater
(P<0.001) in relation to concurrent systolic CBP. In categorized analyses of baseline data, sustained hypertension or masked
hypertension compared with normotension or white-coat hypertension was associated with greater LAVI (24.0 versus 22.6 mL/
m2) and E/e0 (7.35 versus 6.91) and lower e0 (10.7 versus 11.6 cm/s; P≤0.006 for all) with no differences (P≥0.092) between
normotension and white-coat hypertension or between masked hypertension and sustained hypertension.
Conclusions-—ABP is a long-term predictor of diastolic left ventricular function, statistically outperforming distant but not
concurrent CBP. Masked hypertension and sustained hypertension carry equal risk for deterioration of diastolic left ventricular
function. ( J Am Heart Assoc. 2018;7:e007868. DOI: 10.1161/JAHA.117.007868.)
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I n view of the epidemiological transition, heart failure (HF)is a major public health problem.1 Diastolic HF, also
referred to as HF with preserved ejection fraction, accounts
for 50% of cases.2 Mortality of diastolic HF is 30% within
1 year of the ﬁrst hospital admission.3 Subclinical diastolic
left ventricular (LV) dysfunction has a prevalence of 25% in the
general population,4,5 predisposes to further deterioration of
LV function,6 and ﬁnally evolves to overt HF.2 Raised blood
pressure is the major risk factor associated cross-section-
ally4,5,7 and prospectively6,8–10 with diastolic LV dysfunction
in the general population. Most studies making this point
relied on conventional ofﬁce blood pressure. However, all
current hypertension guidelines11–14 endorse the use of
ambulatory monitoring as the state-of-the-art method for
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monitoring blood pressure, because the greater number of
readings obtained over the whole day outside the medical
environment enhance risk stratiﬁcation.
The single prospective population study of diastolic LV
dysfunction10 that applied ambulatory monitoring covered a
narrow age range (40–59 years), only reported on the
echocardiographically assessed LV ﬁlling pressure, did not
compare the predictive value of ambulatory versus ofﬁce
blood pressure, and did not report on diastolic LV function in
truly normotensive people versus patients with white-coat,
masked, or sustained hypertension. To address these knowl-
edge gaps, we analyzed the database of the FLEMENGHO
(Flemish Study on Environment, Genes and Health Out-
comes).4,6,15 We assessed to what extent ofﬁce compared
with ambulatory blood pressure predicted over a 10-year span
multiple echocardiographic indexes capturing diastolic LV
function, ﬁrst in all people combined, and next in participants
categorized according to the guideline-endorsed operational
thresholds of their baseline ofﬁce and ambulatory blood
pressure.
Methods
Study Population
FLEMENGHO complies with the Helsinki declaration for
research in human subjects.16 The Ethics Committee of the
University of Leuven approved the study. At each contact,
participants renewed informed written consent. The data,
analytic methods, and study materials will not be made
available to other researchers for purposes of reproducing the
results or replicating the procedure, because informed
consent did not cover this option. Recruitment started in
1985 and continued until 2004.4,6,15 The initial participation
rate was 78.0%. Of 3343 participants enrolled from 1985 until
2004, 2904 had their daytime ambulatory blood pressure
measured (1989–2008) and afterwards 828 underwent
echocardiography (2005–2010). The participation rate for
ambulatory blood pressure monitoring and echocardiography
amounted to 94.7% and 76.0%, respectively. In the context of
this article, baseline and follow-up, respectively, refer to the
timing of blood pressure monitoring and echocardiography
(Figure 1).
We excluded participants from analysis if the daytime
ambulatory blood pressure was the mean of <10 readings
(n=35), if diastolic LV function could not be reliably graded,
because of image quality (n=16), atrial ﬁbrillation (n=8), or
paced heart rhythm (n=3). This left 790 participants with both
conventional and ambulatory blood pressure measured and
with gradable echocardiographic images. Finally, we excluded
10 participants because their blood pressure levels were
>3 SDs higher than the population mean. Thus, the number of
participants statistically analyzed totaled 780.
Clinical Measurements
Nurses measured blood pressure at baseline17 and follow-up
by auscultation of the Korotkoff sounds. After the participants
had rested for 5 minutes in the sitting position, the observers
obtained 5 consecutive blood pressure readings (phase V
diastolic pressure) to the nearest 2 mm Hg, using mercury
sphygmomanometers. Standard cuffs had a 12924-cm
inﬂatable portion, but if upper arm girth exceeded 31 cm,
larger cuffs with 15935-cm bladders were used. For analysis,
the 5 blood pressure readings obtained at baseline or at
follow-up were averaged. From baseline to follow-up, we
implemented a stringent quality control program described
elsewhere.18,19 Hypertension on conventional blood pressure
measurement was a blood pressure ≥140 mm Hg systolic or
90 mm Hg diastolic.
At baseline, participants wore validated20 SpaceLabs
90204 or 90207 portable monitors (Spacelabs Healthcare,
Snoqualmie, WA) to record their daytime ambulatory blood
pressure from 8 AM until 10 PM at 20-minute intervals. As an
alternative, they could also opt having their blood pressure
monitored over 24 hours, but for the current study only the
daytime part of these recordings was analyzed. The record-
ings were sparsely edited, removing only readings labeled
with an error code or with lower systolic than diastolic blood
pressure level. For continuous analyses,21 we computed the
Clinical Perspective
What Is New?
• Data obtained in a general population are less prone to bias
than studies performed in hypertensive populations.
• Our literature search did not identify any longitudinal study
comparing associations of multiple indexes of diastolic left
ventricular function with conventional versus daytime
ambulatory blood pressure and linking blood pressure
categories at baseline with diastolic left ventricular function
at follow-up.
What Are the Clinical Implications?
• The take-home message of our current study is that multiple
measurements of blood pressure outside the medical
environment are superior to fewer measurements by
observers to screen for diastolic left ventricular dysfunction
and that ambulatory monitoring, as already proposed more
than a decade ago by Thomas Pickering and as reiterated in
contemporary guidelines, is the state-of-the-art technique
for assessing blood pressure in clinical practice and
research.
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daytime blood pressure as the within-individual mean of the
readings between 10 AM and 8 PM weighted for the interval
between readings. This short deﬁnition of daytime eliminates
the transition periods in the morning and evening during
which blood pressure changes rapidly in most people and
approximates within 1 to 2 mm Hg to the wakeful blood
pressure recorded by the diary method.22 In categorical
analyses, ambulatory hypertension was a daytime blood
pressure of 135 mm Hg systolic or 85 mm Hg diastolic or
higher.13 Normotension and sustained hypertension were a
consistently normal or elevated blood pressure on conven-
tional and ambulatory measurement. White-coat hypertension
was a raised conventional blood pressure in the presence of a
normal daytime blood pressure. Masked hypertension was an
elevated ambulatory blood pressure with normal conventional
blood pressure. Participants were categorized based on blood
pressure levels only, irrespective of treatment with antihyper-
tensive drugs.23
Echocardiography
The acquisition and off-line analysis of the echocardiographic
images were done according to current guidelines.24,25
Previous publications describe the procedures applied for
acquisition and the off-line analysis of the echocardiographic
measurements in detail.4,6 In short, digitally stored echocar-
diographic images, obtained with a Vivid7 Pro (GE Vingmed,
Horten, Norway) interfaced with a 2.5- to 3.5-MHz phased-
array probe, were averaged over 3 heart cycles. End-diastolic
LV dimensions were used to calculate LV mass by an
anatomically validated formula according to the recommen-
dations of the American Society of Echocardiography.24,25
Left atrial (LA) volume was calculated using the prolate-
elipsoid method. Diastolic LV function was assessed by
EchoPac software, version 4.0.4 (GE Vingmed). We deter-
mined early (E) and late (A) diastolic peak velocities of the
transmitral blood ﬂow from the pulsed Doppler signal and
early (e0) and late (a0) peak velocities of the mitral annular
movement by tissue Doppler imaging. The tissue Doppler
imaging measurements were averaged over 4 acquisition sites
(septal, lateral, inferior, and posterior). The intraobserver
reproducibility of the single observer in the study (T.K.),
deﬁned as the 2-SD interval about the mean of the relative
differences between duplicate readings, across the 4 tissue
Doppler imaging sampling sites, ranged from 4.5% to 5.3% for
e0 and from 4.0% to 4.5% for a0.6
Figure 1. Flowchart summarizing inclusion of participants in the study. ABPM refers to ambulatory blood
pressure (BP) measurement.
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Other Measurements
The study nurses counted heart rate for 1 minute and
measured the participants’ anthropometric characteristics.
Body mass index was weight in kilograms divided by height in
meters squared. They also administered a standardized
questionnaire inquiring into each participant’s medical history,
smoking and drinking habits, and intake of medications.
Consumption of alcohol was a daily intake of at least 5 g of
ethanol per day.26 Plasma glucose and total serum cholesterol
were measured using automated methods in a single certiﬁed
laboratory. Diabetes mellitus was a fasting or random glucose
level exceeding 126 or 200 mg/dL (7.0 or 11.1 mmol/L), or
use of antidiabetic agents.27
Statistical Analysis
For database management and statistical analysis, we used
SAS software, version 9.4. We compared means and propor-
tions between groups by ANOVA and the v2 statistic,
respectively. We applied a paired t test and McNemar test
to assess changes over time in means and proportions.
Statistical signiﬁcance was a 2-sided signiﬁcance level of
0.05.
In exploratory analyses, we plotted the sex- and age-
adjusted indexes of diastolic LV function by ﬁfths of the
distributions of conventional and daytime blood pressure at
baseline. As described before,4,6 covariables in the multivari-
able-adjusted analyses included sex, the baseline character-
istics age, body mass index, heart rate, serum total
cholesterol, plasma glucose, c-glutamyltransferase (index of
alcohol intake)28 and smoking, use of lipid-lowering treatment
at follow-up, 3 indicator variables coding for starting,
stopping, or continuing antihypertensive drug treatment from
baseline to follow-up, and duration of follow-up. We computed
the variance inﬂation factor from regression models that
included both conventional and daytime blood pressure.29 The
ﬁnal multivariable-adjusted estimates were derived from
mixed models that accounted for family clusters modeled as
a random effect with the other covariables entered as ﬁxed
effects. In sensitivity analyses, we modeled diastolic LV
function indexes in relation to the daytime blood pressure at
baseline and the conventional blood pressure at follow-up.
Results
Characteristics of Participants
All 780 participants were white Europeans, of whom 403
(51.7%) were women. The study population consisted of 116
singletons and 664 related subjects, belonging to 131 one-
generation families and to 61 complex pedigrees. Table 1
shows the clinical characteristics at baseline and follow-up. In
all participants (Table 1), mean baseline values were
40.2 years for age, 121.8/75.4 and 123.0/76.0 mm Hg for
systolic/diastolic blood pressure on conventional and daytime
ambulatory measurement, and 25.0 kg/m2 for body mass
index. Median follow-up was 9.6 years (5th–95th percentile
interval, 5.5–16.1 years). From baseline to follow-up
(Table 1), the prevalence of smoking decreased from 26.5%
to 21.2%, whereas the proportion of people drinking 5 g
alcohol or more daily increased from 23.6% to 40.6%. Body
mass index, the prevalence of overweight and obesity,
conventional blood pressure, and treatment rates for hyper-
tension and dyslipidemia increased from baseline to follow-up.
Serum total cholesterol and plasma glucose decreased over
time.
Associations With Blood Pressure
The median number of readings averaged to estimate the
daytime ambulatory blood pressure was 32 (5th–95th
percentile interval, 20–40; range, 11–43). Mean values
(SD) of the echocardiographic measurements at follow-up
were the following: 22.86.30 mL/m2 and 91.321.4 g/m2
for the LA volume and LV mass indexes; 75.416.0 cm/s,
64.516.7 cm/s, and 1.260.48 for transmitral E, A, and E/
A; 11.53.6 cm/s, 10.12.1 cm/s, and 1.260.64 for the
tissue Doppler imaging indexes e0, a0, and e0/a0; and
6.981.91 for E/e0. In exploratory analyses, only adjusted
for sex and age (Figure 2), the LA volume index and E/e0
increased (P≤0.007) and e0 decreased (P=0.001) with higher
daytime systolic blood pressure, whereas the corresponding
associations were directionally similar for systolic blood
pressure on conventional measurement (P≤0.002), but not
signiﬁcant for the LA volume index (P=0.12).
In multivariable-adjusted mixed models that accounted for
family clusters (Table 2), the LV mass and LA volume indexes
increased with higher systolic and diastolic daytime pressure
(P≤0.004), but not with higher conventional pressure
(P≥0.14). The association sizes per 10/5-mm Hg increment
in systolic/diastolic daytime blood pressure were 2.20/
1.26 g/m2 and 0.62/0.31 mL/m2. The e0 peak velocity
decreased with higher conventional (0.16 cm/s; P<0.001)
and daytime (0.24 cm/s; P<0.001) diastolic blood pressure.
E/e0 increased with higher conventional (+0.15; P=0.001) and
daytime (+0.23; P<0.001) systolic blood pressure.
In regression models that related the echocardiographic
indexes to both conventional and daytime ambulatory blood
pressure and included the ﬁxed-effect covariables, variance
inﬂation factor was consistently lower than 2.0. In mixed
models that included both blood pressure components,
ﬁndings were conﬁrmatory (Table 2). LV mass and LA volume
indexes and E/e0 increased with higher systolic and diastolic
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daytime pressure (P≤0.028), but not with higher conventional
pressure (P≥0.086). The association sizes per 10/5-mm Hg
increment in systolic/diastolic daytime blood pressure were
2.20/1.53 g/m2, 0.65/0.40 mL/m2, and 0.17/0.09. The e0
peak velocity decreased with higher conventional
(0.09 cm/s; P=0.032) and daytime (0.19 cm/s;
P<0.001) diastolic blood pressure. In multivariable-adjusted
analyses additionally accounting for baseline conventional
pulse pressure, a 10-mm Hg higher daytime ambulatory pulse
pressure was associated with a 0.20 greater E/e0 ratio
(P=0.044).
Last, we replaced the conventional blood pressure mea-
sured at baseline by the ofﬁce blood pressure measured
concurrently with echocardiography (Table 3). Variance inﬂa-
tion factor for all of these models was lower than 1.6. LV
mass and LA volume indexes and E/e0 increased with higher
systolic and diastolic daytime pressure (P≤0.036). The
association sizes per 10/5-mm Hg increment in systolic/
diastolic daytime blood pressure were 1.60/0.96 g/m2,
0.45/0.38 mL/m2, and 0.15/0.08. LV mass and LA volume
indexes and E/e0 increased with higher conventional systolic
pressure (P≤0.002). The association sizes per 10-mm Hg
increment in systolic conventional blood pressure were
1.44 g/m2, 0.53 mL/m2, and 0.19. The e0 peak velocity
decreased with higher conventional (0.20 cm/s; P<0.001)
and daytime (0.17 cm/s; P<0.001) diastolic blood pressure
(Table 3).
Associations With Blood Pressure Category
Of the 780 participants, at baseline, 604 (77.4%) were truly
normotensive based on their conventional and daytime blood
pressure and 54 (6.9%), 74 (9.5%), and 48 (6.2%) had white-
coat, masked, or sustained hypertension. Among 54 white-
coat hypertensive patients, the conventional blood pressure
thresholds were met by 28 participants (51.8%) for systolic
Table 1. Characteristics of 780 Participants at Baseline and Follow-Up
Characteristic Baseline Follow-Up P Value
Number with characteristics (%)
Current smoker 207 (26.5) 165 (21.2) <0.001
Drinking alcohol ≥5 g/d 184 (23.6) 317 (40.6) <0.001
Overweight 296 (38.0) 344 (44.1) <0.001
Obesity 77 (9.9) 137 (17.6) <0.001
Diabetes mellitus 8 (1.0) 29 (3.7) <0.001
Conventional hypertension 143 (18.3) 312 (40.0) <0.001
Daytime hypertension 122 (15.6) 
On antihypertensive drugs 61 (7.8) 185 (23.7) <0.001
Lipid-lowering treatment 16 (2.0) 112 (14.4) <0.001
Mean of characteristic (SD)
Age, y 40.214.4 50.615.4 <0.001
Body mass index, kg/m2 25.04.1 26.44.2 <0.001
Conventional blood pressure
Systolic, mm Hg 121.813.8 128.717.1 <0.001
Diastolic, mm Hg 75.410.2 79.59.4 <0.001
Daytime blood pressure
Systolic, mm Hg 123.09.9 
Diastolic, mm Hg 76.07.8 
Heart rate, bpm 69.110.0 63.59.5 <0.001
Total cholesterol, mmol/L 5.331.11 5.240.96 0.013
Plasma glucose, mmol/L 4.981.28 4.940.81 0.38
Geometric mean (IQR) of characteristic
c-Glutamyltransferase (U/L) 21.4 (12.9–31.6) 22.9 (15.1–32.4) <0.001
Body mass index was body weight in kilogram divided by height in meters squared. Overweight and obesity refer to a body mass index of 25 to 29.9 and ≥30 kg/m2, respectively.
Conventional hypertension was a blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic. Daytime hypertension was a blood pressure of ≥135 mm Hg systolic or ≥85 mm Hg
diastolic. P values indicate the signiﬁcance of the difference between baseline and follow-up. IQR indicates interquartile range.
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pressure, by 17 (31.5%) for diastolic pressure, and by 9
(16.7%) for systolic and diastolic blood pressure. Among the
74 participants with masked hypertension, 9 (12.2%) satisﬁed
the daytime threshold for systolic pressure, 13 (17.6%) the
diastolic threshold, and 52 (70.3%) both.
Table 4 shows the echocardiographic traits by cross-
classiﬁcation based on the baseline conventional and
daytime blood pressure. Compared with participants with
true normotension, patients with ambulatory hypertension at
baseline (15.6%) had larger LV mass index (102.7 versus
Table 2. Echocardiographic Indexes at Follow-Up in Relation to Baseline Blood Pressure
Model Echocardiographic Index
Systolic Blood Pressure Diastolic Blood Pressure
Conventional Daytime Conventional Daytime
Single blood pressure
LV mass index, g/m2 0.82 (0.26 to 1.90) 2.20 (0.80–3.60)† 0.01 (0.72 to 0.69) 1.26 (0.39–2.13)†
LA volume index, mL/m2 0.18 (0.14 to 0.51) 0.62 (0.20–1.04)† 0.06 (0.27 to 0.16) 0.31 (0.05–0.57)*
e0 peak, cm/s 0.10 (0.23 to 0.02) 0.15 (0.31 to 0.009) 0.16 (0.24 to 0.08)‡ 0.24 (0.34 to 0.14)‡
E/e0 ratio 0.15 (0.06–0.24)† 0.23 (0.11–0.34)‡ 0.004 (0.06 to 0.06) 0.07 (0.0004–0.15)*
Twin blood pressure
LV mass index, g/m2 0.01 (1.21 to 1.24) 2.20 (0.60–3.79)† 0.52 (1.29 to 0.24) 1.53 (0.58–2.48)†
LA volume index, mL/m2 0.05 (0.42 to 0.32) 0.65 (0.17–1.12)† 0.19 (0.42 to 0.05) 0.40 (0.12–0.69)†
e0 peak, cm/s 0.06 (0.02 to 0.08) 0.11 (0.29 to 0.07) 0.09 (0.18 to 0.008)* 0.19 (0.30 to 0.09)‡
E/e0 ratio 0.09 (0.01 to 0.20) 0.17 (0.04–0.30)* 0.03 (0.10 to 0.03) 0.09 (0.01–0.17)*
Association sizes (95% conﬁdence interval) express the differences in the echocardiographic indexes associated with a 10-mm Hg higher baseline systolic blood pressure or a 5-mm Hg
higher diastolic blood pressure. All models account for clustering within families and were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total
cholesterol, plasma glucose, c-glutamyltransferase (index of alcohol intake) and smoking, use of lipid-lowering treatment at follow-up, 3 indicator variables coding for starting, stopping, or
continuing antihypertensive drug treatment from baseline to follow-up, and duration of follow-up. Single blood pressure models include the conventional or daytime blood pressure and
twin models both. LV mass index was available in 750 participants, LA volume index in 763 and e0 and E/e0 in 780. E indicates early diastolic peak velocities; e0 , early peak velocities of
mitral annular movement; LA, left atrial; LV, left ventricular.
Signiﬁcance of the associations: *P≤0.05; †P≤0.01; and ‡P≤0.001.
Figure 2. Sex- and age-adjusted left atrial volume index (A), e0 (B), and E/e0 (C) at follow-up by quintiles of the distribution of baseline systolic
blood pressure on conventional (open circles) or daytime ambulatory (closed dots) blood pressure measurement. Vertical bars denote the SE. P
values are for linear trend.
DOI: 10.1161/JAHA.117.007868 Journal of the American Heart Association 6
Diastolic LV Function Predicted by Blood Pressure Wei et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on January 22, 2019
89.3 g/m2; P<0.001), LA volume index (25.4 versus
22.3 mL/m2; P<0.001) and E/e0 ratio (7.64 versus 6.86;
P<0.001), and smaller e0 (9.6 versus 11.8 cm/s; P<0.001)
at follow-up. Sustained or masked hypertension at baseline
compared with normotension or white-coat hypertension
(Figure 3) were associated with greater LA volume index
(24.0 versus 22.6 mL/m2; P=0.006) and E/e0 (7.35 versus
6.91; P=0.005) and lower e0 (10.7 versus 11.6 cm/s;
P<0.001) with no differences between normotension and
white-coat hypertension (P≥0.16) or between masked and
sustained hypertension (P≥0.092). A sensitivity analysis from
which we excluded 61 participants on antihypertensive drug
treatment at baseline produced conﬁrmatory results
(Table 4).
Discussion
The key ﬁnding of our study was that ambulatory blood
pressure is a long-term predictor of diastolic LV function
statistically outperforming distant but not concurrent conven-
tional blood pressure, and that masked and sustained
hypertension are equal predictors of worse diastolic LV
function over a 10-year horizon. Concurrent conventional
blood pressure might directly inﬂuence the LV loading
conditions and LV ﬁlling. This might explain why conventional
concurrent compared with distant baseline blood pressure
performed better in the associations with the indexes of LV
diastolic function. The clinical implication is that ambulatory
blood pressure monitoring is a prerequisite for the long-term
Table 4. Echocardiographic Indexes by Hypertension Category at Baseline
Echocardiographic Indexes Normotension White-Coat Hypertension Masked Hypertension Sustained Hypertension PNT PWT PMT
All (n=780) 604 54 74 48
LV mass index, g/m2 90.10.70 90.32.4 97.22.0 99.32.7 0.002 0.011 0.52
Ejection fraction, % 68.20.31 70.61.0 70.20.88 69.71.2 0.23 0.58 0.74
LA volume index, mL/m2 22.60.22 21.70.73 23.40.61 25.10.82 0.004 0.001 0.092
e0 peak, cm/s 11.60.08 11.40.27 10.50.23 11.00.30 0.033 0.23 0.20
E/e0 ratio 6.890.06 7.130.21 7.340.17 7.390.23 0.038 0.39 0.86
Baseline Untreated (n=719) 569 42 69 39
LV mass index, g/m2 89.20.70 93.02.6 96.22.0 97.33.0 0.034 0.29 0.98
Ejection fraction, % 68.10.32 71.31.2 70.10.91 69.11.3 0.50 0.20 0.53
LA volume index, mL/m2 22.30.23 21.90.84 23.30.65 25.10.94 0.008 0.004 0.14
e0 peak, cm/s 11.90.08 11.50.31 10.80.24 11.30.34 0.069 0.62 0.24
E/e0 ratio 6.790.06 7.040.22 7.200.17 7.040.24 0.33 0.99 0.60
Values are meanSE. All estimates account for clustering within families. Estimates were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total
cholesterol, plasma glucose, c-glutamyltransferase (index of alcohol intake) and smoking, for use of lipid-lowering treatment at follow-up, for 3 indicator variables coding for starting,
stopping, or continuing antihypertensive drug treatment from baseline to follow-up, and for duration of follow-up. LV mass index (untreated at baseline) was available in 750 (694)
participants, ejection fraction in 708 (655), LA volume index in 763 (703), and e0 and E/e0 in 780 (719). E indicates early diastolic peak velocities; e0 , early peak velocities of mitral annular
movement; LA, left atrial; LV, left ventricular; PMT, the signiﬁcance of the difference between masked hypertension and sustained hypertension; PNT, the signiﬁcance of the difference
between normotension and sustained hypertension; PWT, the signiﬁcance of the difference between white-coat hypertension and sustained hypertension.
Table 3. Echocardiographic Indexes at Follow-Up in Relation to Baseline Daytime and Follow-Up Conventional Blood Pressure
Model Echocardiographic Index
Systolic Blood Pressure Diastolic Blood Pressure
Follow-Up Conventional Baseline Daytime Follow-Up Conventional Baseline Daytime
LV mass index, g/m2 1.44 (0.54–2.33)† 1.60 (0.17–3.04)* 0.55 (0.24 to 1.33) 0.96 (0.06–1.86)*
LA volume index, mL/m2 0.53 (0.26–0.79)‡ 0.45 (0.03–0.88)* 0.17 (0.41 to 0.06) 0.38 (0.12–0.65)†
e0 peak, cm/s 0.04 (0.14 to 0.05) 0.11 (0.26 to 0.04) 0.20 (0.28 to 0.12)‡ 0.17 (0.27 to 0.08)‡
E/e0 ratio 0.19 (0.12–0.26)‡ 0.15 (0.03–0.26)* 0.01 (0.05 to 0.08) 0.08 (0.01–0.16)*
Association sizes (95% conﬁdence interval) express the differences in the echocardiographic indexes associated with a 10-mm Hg higher systolic blood pressure or a 5-mm Hg higher
diastolic blood pressure. All models included both blood pressure components, account for clustering within families, and were adjusted for sex, the follow-up characteristics age, body
mass index, heart rate, serum total cholesterol, plasma glucose, c-glutamyltransferase (index of alcohol intake) and smoking, and use of lipid-lowering treatment, 3 indicator variables
coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow-up, and duration of follow-up. LV mass index was available in 750 participants, LA
volume index in 763, and e0 and E/e0 in 780. E indicates early diastolic peak velocities; e0 , early peak velocities of mitral annular movement; LA, left atrial; LV, left ventricular. Signiﬁcance
of the associations: *P≤0.05; †P≤0.01; and ‡P≤0.001.
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risk stratiﬁcation for impaired diastolic LV function in relation
to blood pressure. Only out-of-the ofﬁce blood pressure
monitoring allows differentiation between true normotension
and risk-carrying masked hypertension23 among individuals
with normal ofﬁce blood pressure or between low-risk white-
coat hypertension30 and sustained hypertension.
To our surprise, a thorough literature search of the PubMed
database, using as search terms “blood pressure” OR
“ambulatory blood pressure” OR “hypertension” AND “heart”
OR “left ventricular diastolic function” revealed only 1 other
longitudinal population study relating E/e0 at follow-up to the
ambulatory blood pressure measured 20 years earlier.10 This
Finnish study included 414 individuals enrolled in the OPERA
(Oulu Project Elucidating Risk of Atherosclerosis) study.10 Age
ranged from 40 to 59 years. E/e0 was the only echocardio-
graphic index of diastolic LV function reported and analyzed
as a categorical variable using a threshold of 15 to
discriminate between normal (n=381) and impaired (n=33)
diastolic LV performance. With adjustments applied for sex,
age, stature, body mass index, prevalence of diabetes
mellitus, ofﬁce systolic and pulse pressure, N-terminal pro-
atrial natriuretic peptide, and the use of antihypertensive
therapy, there was no association between diastolic LV
dysfunction and the 24-hour, daytime or nighttime systolic or
diastolic blood pressure. However, with additional adjustment
for ambulatory diastolic blood pressure, diastolic LV dysfunc-
tion at follow-up was associated with higher baseline pulse
pressure on 24-hour (53.4 versus 46.4 mm Hg; P=0.001),
daytime (54.3 versus 47.0 mm Hg; P=0.016), and nighttime
blood pressure measurements (51.2 versus 44.2 mm Hg;
P=0.015).10 This Finnish study did not compare the predictive
performance of the ofﬁce and ambulatory blood pressure and,
in view of the low number of cases and the complex
adjustments for highly intercorrelated covariables, remains
difﬁcult to interpret.
The Finnish OPERA study8 and the United Kingdom Medical
Research Council National Survey of Health and Development9
reported on the longitudinal associations between diastolic LV
function and the conventional blood pressure. Using the same
approach as in their article on ambulatory blood pressure,10
the OPERA investigators demonstrated that greater in-ofﬁce
systolic blood pressure, shorter height, and lower estimated
glomerular ﬁltration rate in middle-aged people were forerun-
ners of diastolic dysfunction 20 years later.8 In 1653 single-
tons enrolled in the Medical Research Council National Survey
of Health and Development birth cohort, investigators mea-
sured the participants’ conventional blood pressure, using the
Hawskley random-zero sphygmomanometer or an oscillomet-
ric device at ages 36, 43, 53, and 60 to 64 years.9 At the last
follow-up visit, diastolic LV function was also assessed.
Increased systolic blood pressure at 36, 43, and 53 years
was predictive of increased E/e0 and increased LA volume
index. These effects were only partially explained by systolic
blood pressure at 60 to 64 years or increased LV mass.
Antihypertensive drug treatment was also associated with
poorer diastolic function after adjustment for systolic blood
pressure at age 60 to 64 years. The authors concluded that
faster rates of increase in systolic blood pressure in midlife
were associated with poorer diastolic function.9
In categorized analyses of baseline data, we demonstrated
that sustained or masked hypertension compared with
normotension or white-coat hypertension was associated
Figure 3. Multivariable-adjusted means of left atrial volume index (A), e0 (B), and E/e0 (C) at follow-up by hypertension category at baseline.
NT, WHT, MHT, and SHT indicate true normotension and white-coat, masked, and sustained hypertension, respectively. Estimates given with SE
account for clustering within families and were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total
cholesterol, plasma glucose, c-glutamyltransferase (index of alcohol intake) and smoking, for use of lipid-lowering treatment at follow-up, for 3
indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow-up, and for duration of
follow-up. Left atrial volume index was available in 763 participants and e0 and E/e0 in 780. P values are for the between-group comparisons.
LAVI indicates left atrial volume index.
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with greater LA volume index and E/e0 and lower e0 with no
differences between normotension and white-coat hyperten-
sion30 or between masked and sustained hypertension. Data
obtained in a general population are less prone to bias than
studies performed in hypertensive populations. Our literature
search did not identify any longitudinal study linking blood
pressure categories at baseline with diastolic LV function at
follow-up. In a cross-sectional study of 52 111 Korean adults
who had their ofﬁce blood pressure measured oscillometri-
cally and who were examined echocardiographically, the
adjusted mean E/e0 ratio was 7.56 in normotensive people,
7.89 and 8.17 in prehypertensive and controlled hypertensive
patients, and 8.28 and 8.54 in newly diagnosed and
uncontrolled patients.31 The LV mass and LA volume indexes
showed similar trends.31 The International Database on
Ambulatory blood pressure monitoring in relation to Cardio-
vascular Outcome includes randomly enrolled population
samples who had ofﬁce and ambulatory blood pressure and
cardiovascular risk factors measured at baseline with a
longitudinal follow-up of fatal and nonfatal cardiovascular
outcomes.23 Using a daytime threshold of 135/85 mm Hg,13
the prevalence of normotension and white-coat, masked, and
sustained hypertension was 49.4%, 10.6%, 14.6%, and 25.4%,
respectively.23 The multivariable-adjusted risk associated with
white-coat hypertension did not differ from normotension,
whereas masked hypertension conferred a risk not different
from that of sustained hypertension.23 Our current study
extends the International Database on Ambulatory blood
pressure monitoring in relation to Cardiovascular Outcome
ﬁndings to a trait reﬂecting intermediate target organ damage
(ie, diastolic LV dysfunction).
The clinical implications of our current ﬁndings can be
gauged against the prognosis associated with asymptomatic
diastolic LV dysfunction, which in the general population has a
prevalence of around 25%4,5 and over time evolves to
symptomatic LV dysfunction6 and heart failure2 and predicts
the incidence of adverse health outcomes. Guideline-driven
echocardiographic criteria24,25 to stage patients with
advanced diastolic LV dysfunction leave a large proportion
of people unclassiﬁed in population studies. As we reported
previously,32 the threshold of 7 cm/s for e0 corresponds with
the 10th percentile of the distribution in the current study
population and the thresholds 14 for E/e0 and 34 mL/m2 for
LAVI are equivalent to the 95th percentiles of their distribu-
tion. Among 793 Flemish followed up for 5 years, the
multivariable-adjusted hazard ratios per 1-SD decrease
(P=0.001) in e0 amounted to 2.50 and 3.66 for cardiovascular
and cardiac complications, respectively.33 Furthermore, in
2042 participants enrolled in the Olmsted County Study34 and
followed up for 3.5 years, mild (20.8%) and moderate-to-
severe (7.3%) diastolic LV dysfunction at baseline predicted
all-cause mortality with hazard ratios of 8.3 and 10.2
(P<0.001). In the Framingham Heart Study, remote blood
pressure (average of all reading 11–20 years before current)
and recent blood pressure (average of all reading 1–10 years
before current) predicted the risk of cardiovascular disease
incrementally over current blood pressure.35 This observation
was consistent irrespective of sex and age.35 Explanations
offered by the Framingham investigators were that ante-
cedent blood pressure is a forerunner of cardiovascular target
organ damage, which is on the path to hard cardiovascular
complications, and that the relation between cardiovascular
risk and blood pressure weakens over time by the initiation of
antihypertensive drug treatment.35 What our current study
adds is that ambulatory blood pressure is a long-term
predictor of diastolic LV function, statistically outperforming
distant but not concurrent conventional blood pressure.
Our current study must be interpreted within the context of
some potential limitations. First, in line with current practice,13
we used daytime not 24-hour ambulatory or nighttime blood
pressure to categorize our participants. Our study participants
could opt to have their 24-hour blood pressure monitored.
However, in view of the discomfort caused by nighttime blood
pressure readings, only 290 had whole-day recordings.
Participants opting for 24-hour instead of daytime-only
monitoring had similar sex distribution and prevalence of
smoking and plasma glucose (P≥0.36), but were on average
6.0 years older and therefore had a slightly but signiﬁcantly
(P≤0.038) higher body mass index, blood pressure, serum
cholesterol, and plasma glucose. Previous studies demon-
strated that using daytime or 24-hour blood pressure yields
similar proportions of patients with white-coat and masked
hypertension36 as well as similar estimates of cardiovascular
risk.37 Second, the prevalence of white-coat hypertension in
our study was about two thirds less as compared with other
studies of populations23,37 and patients.36 However, our
participants were repeatedly followed up by the same team of
study nurses living in the catchment area of the study.
Familiarization of participants with the study team is a likely
explanation of the low prevalence of white-coat hypertension
and the 5.6-beat/min decrease in heart rate from baseline to
follow-up.38 Finally, our study included only white Europeans.
However, in the international multiethnic International
Database on Ambulatory blood pressure monitoring in relation
to Cardiovascular Outcome study, there were no differences
in the risks associated with blood pressure among Europeans,
Asians, and South Americans.37
In conclusion, ambulatory blood pressure is a long-term
predictor of diastolic LV function outperforming distant but
not concurrent conventional blood pressure. Masked and
sustained hypertension carry equal risk for deterioration of
diastolic LV function. The take-home message of our current
study is that multiple measurements of blood pressure
outside the medical environment are superior to fewer
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measurements by observers to screen for diastolic LV
dysfunction and that ambulatory monitoring, as already
proposed more than a decade ago by Thomas Pickering39
and as reiterated in contemporary guidelines,11–14 is the
state-of-the-art technique for assessing blood pressure in
clinical practice and research.
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